Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWRonidazole is a carbamate ester with antiprotozoal and antibiotic activities.1 It is active against a panel of T. foetus isolates with minimum lethal concentrations (MLCs) ranging from 0.625 to 1.25 µg/ml. It is also active against C. difficile bacteria (MIC90 = 0.125 µg/ml).2 Ronidazole (50 mg/kg) inhibits infection relapse in a cat model of experimental T. foetus infection.3 It also inhibits T. muris infection in mice when administered at a concentration of 400 mg/L in drinking water.4 Ronidazole (10 mg/kg) increases survival in a mouse model of C. difficile infection.2 Formulations containing ronidazole have been used in the treatment of T. foetus infection in cats.
WARNING This product is not for human or veterinary use.
1. Determination of the in vitro susceptibility of feline Tritrichomonas foetus to 5 antimicrobial agents. J. Vet. Intern. Med. 21(5), 966-970 (2007).
2. Repurposing the veterinary antiprotozoal drug ronidazole for the treatment of Clostridioides difficile infection. Int. J. Antimicrob. Agents 56(6), 106188 (2020).
3. Efficacy of ronidazole for treatment of feline Tritrichomonas foetus infection. J. Vet. Intern. Med. 20(3), 536-543 (2006).
4. Use of ronidazole and limited culling to eliminate Tritrichomonas muris from laboratory mice. J. Am. Assoc. Lab. Anim. Sci. 55(4), 480-483 (2016).